Oil prices dropped significantly on Friday, with West Texas Intermediate falling 3.5% to $69.38 per barrel and Brent crude down over 3% to $72.88 per barrel. Both benchmarks are on track for their third consecutive week of losses, declining around 21% since early June. The price drop reflects investors' decision not to factor in heightened risks from Middle East tensions, despite warnings from Iran about shipping routes in the Strait of Hormuz. This easing of geopolitical risk has kept oil supply concerns subdued for now, but any escalation could quickly reverse the trend.
Virtual Investor Conferences announced that presentations from the June 24-25 Life Sciences Virtual Investor Forum are now accessible on-demand for 90 days. This event featured multiple life sciences companies presenting to investors, with opportunit...
Vaxart, a clinical-stage biotech company, has published a presentation urging shareholders to vote for all six of its director nominees at the upcoming Annual Meeting. The company highlights its progress in developing oral vaccines for COVID-19, noro...
Axsome Therapeutics has initiated the FOCUS-3 Phase 3 clinical trial to evaluate solriamfetol as a treatment for adolescents aged 12 to under 18 with ADHD. This randomized, double-blind, placebo-controlled study will enroll about 468 patients to asse...
WuXi AppTec highlights how the increasing structural complexity of small molecules, such as targeted protein degraders and covalent inhibitors, is transforming drug research and development. These new molecules require advanced, integrated approaches...
At its Annual General Meeting on June 25, 2026, Fury Gold Mines shareholders approved fixing the board size at six directors and elected all nominated directors. PricewaterhouseCoopers LLP was appointed as the company's auditor. Shareholders also ren...
